IP Library Granted Patent US 7,942,842
Granted Patent B2
US 7,942,842 · App. 12/043,696 · Granted May 17, 2011

Apparatus and method for the treatment of blood

Assignee: Freeview Ventures LLC
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,942,842
App. No.
12/043,696
Granted
May 17, 2011
Kind
B2
Abstract

The invention relates to an apparatus and a method for the treatment of the blood in a Continuous Renal Replacement Therapy, using a machine which comprises: —connecting means from and to respective blood vessels of a patient; —blood processing means comprising a pump; —means for adding drugs or other therapeutic substances to the blood being treated; —means for feeding refill liquid into the blood; —blood filtration means, cascade-connected to one another by relative conduits, said conduits and said connecting means defining a blood path; wherein the blood to be treated passes through an oxygenating device which comprises an oxygenating membrane and is located upstream from said blood filtration means and downstream from said blood processing means, so that the blood is treated by said oxygenating membrane without the intake pressure along the portion upstream from the blood pump; and wherein the blood is pumped downstream from the connecting means to the oxygenating device at a flow rate of about 280-300 ml/min.

Claims (7)

1. A method for the treatment of blood in a Continuous Renal Replacement Therapy comprising the step of filtering the blood of a patient with a haemofilter disposed on a blood path formed by conduits through which the blood of the patient passes, wherein:

the patient is connected to the haemofilter with a femoral catheter, which is connected to a pump, disposed upstream with respect of the haemofilter and which pumps downstream at a flow rate of about 280-300 ml/min;

said haemofilter having one output connected to a conduit configured for discharging ultrafiltrate into a collecting tank and a second output connected to the patient;

wherein the blood pumped by said pump passes through an oxygenating device comprising an oxygenating membrane located upstream from said haemofilter and downstream from said pump, so that the pumped blood is treated by said oxygenating membrane without intake pressure along the blood path upstream from the blood pump; and

wherein the blood treated by the haemofilter returns to the patient without the ultrafiltrate.

2. The method of claim 1 , wherein the blood and ultrafiltrate are pumped only by one pump, disposed upstream from said oxygenating device.

3. The method of claim 1 , wherein the blood, downstream of said pump and upstream from said oxygenating device is returned with a refill liquid having been infusion heated by heating means.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 29, 2021
From: ECS EXTRA CORPOREAL SOLUTIONS S.R.L.
To: B. BRAUN AVITUM AG
Reel/Frame 055081/0895 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 14, 2015
From: HEMODEC S.R.L.
To: EXTRA CORPOREAL SOLUTIONS S.R.L.
Reel/Frame 037286/0426 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 10, 2011
From: FREEVIEW VENTURES LLC
To: HEMODEC S.R.L.
Reel/Frame 026253/0760 →
Priority Claims (1)
IT FI2002A0208 · Oct 31, 2002 · national
Continuity (2)
Continuation 10699098 · Oct 30, 2003
Related Publication 20080154171A1 · Jun 26, 2008